Covid-19 roundup: Novavax begins PhII trial in US and Australia; AstraZeneca signs US manufacturing deal with Catalent
Novavax is pushing forward with the Phase II portion of a Phase I/II trial for its vaccine in the US …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
